QOL Improvements in NETTER-1 Phase III Trial in Patients With Progressive Midgut Neuroendocrine Tumors Strosberg, J., Wolin, E., Chasen, B., Kulke, M., Bushnell, D., Caplin, M., Baum, R. P., Kunz, P., Hobday, T., Hendifar, A., Oberg, K., Sierra, M., Ruszniewski, P., Krenning, E. LIPPINCOTT WILLIAMS & WILKINS. 2018: 355

View details for Web of Science ID 000426086300102